<DOC>
	<DOCNO>NCT00357110</DOCNO>
	<brief_summary>Purpose compare frequency event ( presence Disseminated Tumour Cells , clinical recurrence and/or death ) 1 2 year adjuvant treatment anastrozole fulvestrant anastrozole alone patient early breast cancer .</brief_summary>
	<brief_title>Anastrozole Fulvestrant Compared Anastrozole Adjuvant Treatment Postmenopausal Patients With Breast Cancer</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Fulvestrant</mesh_term>
	<mesh_term>Anastrozole</mesh_term>
	<mesh_term>Estradiol</mesh_term>
	<criteria>Postmenopausal woman hormone receptorpositive early breast cancer positive Disseminated Tumour Cell immunocytochemical result bone marrow aspiration prior randomisation Inflammatory and/or metastatic breast cancer . Current previous malignancy within previous 5 year ( Breast cancer adequately treat nonmelanoma skin cancer insitu cervical cancer ) . History bleed diathesis .</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2010</verification_date>
	<keyword>Breast neoplasm</keyword>
	<keyword>breast cancer</keyword>
	<keyword>early breast cancer</keyword>
	<keyword>oncology</keyword>
	<keyword>cancer</keyword>
	<keyword>breast cancer micrometastasis</keyword>
	<keyword>fulvestrant</keyword>
</DOC>